Atrial fibrillation and chronic kidney disease: A bad combination.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Direct oral anticoagulants versus vitamin K antagonists for atrial fibrillation patients on dialysis: A systematic review and meta-analysis of randomized controlled trials and real-world evidence.Journal of thrombosis and thrombolysis · 2026
   Pooled it
2. Comparative Renal Outcomes and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation: Insights from Real-World Data.Medicina (Kaunas, Lithuania) · 2026
   Article
3. Increased Risk of Medical and Implant-Related Complications in Patients With Atrial Fibrillation After Primary Total Shoulder Arthroplasty: A 1:1 Propensity-Matched Cohort Analysis.Cureus · 2026
   Article
4. Multiscale segmentation using hierarchical phase-contrast tomography and deep learning.PLoS computational biology · 2026
   Article
5. DOACs vs warfarin in AF with comorbid CKD or valvular disease: a systematic review and meta-analysis.Blood vessels, thrombosis & hemostasis · 2026
   Review
6. Renal Function, Atrial Cardiopathy, and Their Joint Association with Mortality in the General Population.Journal of clinical medicine · 2025
   Article
7. Risk of Chronic Kidney Disease and Implications in Patients with Atrial Fibrillation for the Development of Major Adverse Cardiovascular Events with Machine Learning.Medical sciences (Basel, Switzerland) · 2025
   Article
8. Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
   Article
9. An integrated bioinformatics approach for identification of key modulators and biomarkers involved in atrial fibrillation.Journal of cardiovascular and thoracic research · 2025
   Article
10. Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients.International urology and nephrology · 2025
    Article
11. Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management.Reviews in cardiovascular medicine · 2024
    Review
12. Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink.Journal of arrhythmia · 2024
    Article
13. Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study.Frontiers in cardiovascular medicine · 2024
    Article
14. Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population-Based Study.Journal of the American Heart Association · 2023
    Article
15. Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues.Anatolian journal of cardiology · 2022
    Review
16. Dialysis Mode and Associated Outcomes in Patients With End-Stage Renal Disease and Atrial Fibrillation: A 14-Year Nationwide Cohort Study.Journal of the American Heart Association · 2021
    Article
17. Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2020
    Article
18. Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients.Frontiers in cardiovascular medicine · 2020
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.